Novavax, Inc. (NVAX)

9.725 +0.42 (+4.57%) USD  |  NASDAQ  |  Sep 11, 13:46
More

Novavax Gross Profit (TTM) : 325.46M for June 30, 2026

Gross Profit (TTM) Chart

View Gross Profit (TTM) for NVAX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (TTM) Chart
Start Trial

Historical Gross Profit (TTM) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 325.46M
March 31, 2026 506.42M
December 31, 2025 1.050B
September 30, 2025 964.55M
June 30, 2025 939.59M
March 31, 2025 1.094B
December 31, 2024 486.22M
September 30, 2024 592.65M
June 30, 2024 655.01M
March 31, 2024 644.72M
December 31, 2023 659.04M
September 30, 2023 692.20M
June 30, 2023 895.78M
March 31, 2023 434.76M
December 31, 2022 1.057B
September 30, 2022 1.100B
June 30, 2022 808.66M
March 31, 2022 900.53M
December 31, 2021 218.53M
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
Date Value
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 4.217M
June 30, 2016 7.995M
March 31, 2016 19.30M
December 31, 2015 26.72M
September 30, 2015 26.39M
June 30, 2015 26.80M
March 31, 2015 18.65M
December 31, 2014 15.67M
September 30, 2014 17.93M
June 30, 2014 16.27M
March 31, 2014 15.01M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
Moderna, Inc. 280.00M
Merck & Co., Inc. 48.01B
Pfizer Inc. 41.30B
Recursion Pharmaceuticals, Inc. -48.49M
Agenus, Inc. 127.32M